Top

Clinical and Translational Oncology

Published in:

01-03-2009 | Case Reports

Acute ischaemic cerebrovascular attack secondary to infusional 5-fluoruracil and cisplatin in a patient with advanced gastric cancer

Authors: Ignacio Garrido-Laguna, María de la Luz Amador, Juan Ruiz, Hernán Cortés-Funes

Published in: Clinical and Translational Oncology | Issue 3/2009

Title: Acute ischaemic cerebrovascular attack secondary to infusional 5-fluoruracil and cisplatin in a patient with advanced gastric cancer
Authors: Ignacio Garrido-Laguna
María de la Luz Amador
Juan Ruiz
Hernán Cortés-Funes
Publication date: 01-03-2009
Publisher: Springer Milan
Published in: Clinical and Translational Oncology / Issue 3/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/S12094-009-0336-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2009

Feasibility of adequate resectable rectal cancer treatment in a third-level hospital

Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors?

Beware the node: the more we know, the less aggressive we are

The EORTC Quality of Life Questionnaire for patients with prostate cancer: EORTC QLQ-PR25. Validation study for Spanish patients

What a strange thing it is to live

New approaches to female fertility preservation

Keynote webinar | Spotlight on antibody–drug conjugates in cancer